申请人:Eli Lilly and Company
公开号:US06777428B1
公开(公告)日:2004-08-17
The present invention relates to a compound of formula I and a process for making:
or a pharmaceutical acid addition salt thereof; which are useful for activating 5-HT1F receptors and inhibiting neuronal protein extravasation in a mammal.
本发明涉及一种式I的化合物及其制备方法:
或其药用酸盐;该化合物对于激活哺乳动物中的5-HT1F受体和抑制神经蛋白外渗具有用处。